Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.

Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients, as part of an Australian-first trial.

A recent Mater Research protocol submitted to the NHMRC has demonstrated the vital role consumers play in shaping and improving research trials.